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We thank Drs Sormani, Bruzzi and Mancardi for their critical comments. They claim that 
large part of the neurotoxic effects described in our study may be due to:  
a) detrimental effects of radiation, 
b) a bias introduced by the observational nature of our study and possible 
unequilibrium of baseline features of the matched  samples we compared in our 
study.  
Ad a) : We agree that radiation may have added to the toxicity of chemotherapy and have 
discussed that transparently providing the appropriate references (3,4, 24-29, 46 and 48  
in  1 ) and not “shyly” as insinuated in the letter…  As they may have noted, we and others 
also included patients who underwent chemotherapy without irradiation 6. Again we 
observed a clear cut increase of blood neurofilament levels as a marker of neuronal 
damage 1. 
Ad b) : clearly, an unequilibrium - especially of unknown confounding factors - is always a 
concern if the setting of non randomized observational studies 7, 8. However, the slight and 
non significant difference in brain volumes Sormani et al pointed out is well in the range of 
variability observed even in the setting of randomized patient groups in MS 8. Interestingly, 
the other outcome of our study neurofilament levels was also in some imbalance, but in 
the opposite direction: in the SPMS-PL group, baseline values  were 65% higher than 
those in the SPMS-BMT patients 1.  More importantly, both the neurofilament increase and 
brain volume reduction we observed in the year after BMT were so clearly different and 
accompanied by clinical deterioration (EDSS dropped abruptly after conditioning and this 
drop was sustained over years 1,7)  that there is no reason to doubt about the fact of the 
occurrence of a related neurotoxicity.  
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